Advertisement
Advertisement
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
4.39
USDSponsored
-0.04
-0.79%
May 21, 12:35 UTC -4
Open
MRVI Earnings Reports
Positive Surprise Ratio
MRVI beat 14 of 22 last estimates.
64%
Next Report
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$49.62M
/-$0.04
Implied change from Q1 26 (Revenue/ EPS)
-24.63%
/-500.00%
Implied change from Q2 25 (Revenue/ EPS)
+4.70%
/-50.00%
Maravai LifeSciences Holdings, Inc. Class A Common Stock earnings per share and revenue
On May 07, 2026, MRVI reported earnings of 0.01 USD per share (EPS) for Q1 26, beating the estimate of -0.04 USD, resulting in a 120.79% surprise. Revenue reached 65.84 million, compared to an expected 54.11 million, with a 21.68% difference. The market reacted with a +23.10% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 11 analysts forecast an EPS of -0.04 USD, with revenue projected to reach 49.62 million USD, implying an decrease of -500.00% EPS, and decrease of -24.63% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Omeros Corporation
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.41
Actual
-$0.24
Surprise
+41.90%
Brainsway Ltd. - ADR
Report Date
May 13, 2026 For Q1 26
Estimate
$0.17
Actual
$0.18
Surprise
+6.98%
Valneva SE - ADR
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.18
Surprise
-154.60%
MacroGenics, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.58
Actual
-$0.57
Surprise
+0.45%
FitLife Brands, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
$0.12
Actual
$0.17
Surprise
+33.33%
Immucell Corp
Report Date
May 14, 2026 For Q1 26
Estimate
-Actual
$0.21
Surprise
-
Veru Inc.
Report Date
May 13, 2026 For Q2 26
Estimate
-$0.29
Actual
-$0.12
Surprise
+58.72%
Bonk, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-Actual
-$0.23
Surprise
-
Cellectar Biosciences INC NEW
Report Date
May 14, 2026 For Q1 26
Estimate
-$1.92
Actual
-$1.30
Surprise
+32.39%
Innovative Eyewear, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.47
Actual
-$0.37
Surprise
+22.82%
FAQ
What were Maravai LifeSciences Holdings, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Maravai LifeSciences Holdings, Inc. Class A Common Stock reported EPS of $0.01, beating estimates by 120.79%, and revenue of $65.84M, 21.68% above expectations.
How did the market react to Maravai LifeSciences Holdings, Inc. Class A Common Stock's Q1 2026 earnings?
The stock price moved up 23.1%, changed from $3.94 before the earnings release to $4.85 the day after.
When is Maravai LifeSciences Holdings, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Maravai LifeSciences Holdings, Inc. Class A Common Stock's next earnings report?
Based on 11
analysts, Maravai LifeSciences Holdings, Inc. Class A Common Stock is expected to report EPS of -$0.04 and revenue of $49.62M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement